Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice

Thrombosis Research

Volumn 128, Issue 6, 2011, Pages

  Ding, Renyu ^a   Zhao, Dongmei ^a   Guo, Renxuan ^a   Zhang, Zhidan ^a   Ma, Xiaochun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Coagulation; Inflammation; Septic shock; survival; Thrombosis; Unfractionated heparin

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; HEPARIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; C57BL 6 MOUSE; CONTROLLED STUDY; ENDOTOXEMIA; INFLAMMATION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CYTOKINES; ENDOTOXEMIA; HEPARIN; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82355173316     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.07.044     Document Type: Article

References (51)

1. J.E. Parrillo Pathogenetic mechanisms of septic shock N Engl J Med 328 1993 1471 1477
2. N.C. Riedemann, R.F. Guo, and P.A. Ward Novel strategies for the treatment of sepsis Nat Med 9 2003 517 524 (Pubitemid 36597096)
3. Satoshi Gando Microvascular thrombosis and multiple organ dysfunction Syndrome Crit Care Med 38 2010 S35 S42
4. M. Levi, T.T. Keller, E. van Gorp, and H. ten Cate Infection and inflammation and the coagulation system Cardiovasc Res 60 2003 26 39 (Pubitemid 38373473)
5. Marcel Levi, and Tom van der Poll Inflammation and coagulation Crit Care Med 38 2010 S26 S34
6. J. Carr The anti-inflammatory action of heparin: Heparin as an antagonist to histamine, bradykinin and prostaglandin E1 Thromb Res 16 1979 507 516 (Pubitemid 10207009)
7. D. Hocking, T.J. Ferro, and A. Johnson Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema J Appl Physiol 72 1992 179 185
8. M. Lantz, H. Thysell, E. Nilsson, and I. Olsson On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin J Clin Invest 88 1991 2026 2031
9. R. Lever, J.R. Hoult, and C.P. Page The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro Br J Pharmacol 129 2000 533 540 (Pubitemid 30083875)
10. S. Meri, and M.K. Pangburn A mechanism of activation of the alternative complement pathway by the classical pathway: Protection of C3b from inactivation by covalent attachment to C4b Eur J Immunol 20 1990 2555 2561
11. T. Pernerstorfer, U. Hollenstein, J. Hansen, M. Knechtelsdorfer, P. Stohlawetz, and W. Graninger Heparin blunts endotoxin-induced coagulation activation Circulation 100 1999 2485 2490 (Pubitemid 30005111)
12. H. Gans Mechanism of heparin protection in endotoxin shock Surgery 77 1975 602 606
13. J.P. Filkins, and N.R. Di Luzio Heparin protection in endotoxin shock Am J Physiol 214 1968 1074 1077
14. M.P. Griffin, D.C. Gore, J.B. Zwischenberger, T.E. Lobe, M. Hall, and D.L. Traber Does heparin improve survival in experimental porcine gram-negative septic shock? Circ Shock 31 1990 343 349 (Pubitemid 20220911)
15. S. Yang, and J.G. Hauptman The efficacy of heparin and antithrombin III in fluid-resuscitated cecal ligation and puncture Shock 2 1994 433 437
16. R.A. Gaskins Jr., and F.G. Dalldorf Experimental meningococcal septicemia. Effect of heparin therapy Arch Pathol Lab Med 100 1976 318 324 (Pubitemid 8190710)
17. J.J. Corrigan Jr., and J.F. Kiernat Effect of heparin in experimental gram-negative septicemia J Infect Dis 131 1975 138 143
18. E. Abraham, K. Reinhart, S. Opal, I. Demeyer, C. Doig, and A.L. Rodriguez Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial JAMA 290 2003 238 247 (Pubitemid 37430063)
19. K.H. Polderman, and A.R. Girbes Drug intervention trials in sepsis: Divergent results Lancet 363 2004 1721 1723 (Pubitemid 38670331)
20. Ryan Zarychanski, Steven Doucette, Dean Fergusson, Daniel Roberts, Donald S. Houston, and Satendra Sharma Early intravenous unfractionated heparin and mortality in septic shock Crit Care Med 36 2008 2973 2979
21. J.W. Eikelboom, and J. Hirsh Monitoring unfractionated heparin with the aPTT: time for a fresh look Thromb Haemost 96 2006 547 552 (Pubitemid 44782532)
22. S.H. Slofstra, C. van 't Veer, W.A. Buurman, P.H. Reitsma, H. ten Cate, and C.A. Spek Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation Crit Care Med 33 2005 1365 1370 (Pubitemid 40827391)
23. C.L. Lau, Y. Zhao, J. Kim, I.L. Kron, A. Sharma, and Z. Yang Enhanced Fibrinolysis Protects Against Lung Ischemia-Reperfusion Injury J Thorac Cardiovasc Surg 137 2009 1241 1248
24. R. Pawlinski, B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, and W. Boisvert Role of tissue factor and protease activated receptors in a mouse model of endotoxemia Blood 103 2004 1342 1347 (Pubitemid 38168646)
25. M. Levi, J. Dorffler-Melly, P. Reitsma, H. Buller, S. Florquin, and P.T. Van Der Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice Blood 101 2003 4823 4827 (Pubitemid 36857741)
26. M. Yanada, T. Kojima, K. Ishiguro, Y. Nakayama, K. Yamamoto, and T. Matsushita Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice Blood 99 2002 2455 2458 (Pubitemid 34525432)
27. D.L. Dunn, CerraFB MachPA, and R.M. Ferguson The role of heparin in guinea pigGram negative bacterial sepsis J Surg Res 34 1983 479 485 (Pubitemid 13099746)
28. T. Tanaka, T. Tsujinaka, J. Kambayashi, M. Higashiyama, M. Yokota, and M. Sakon The effect of heparin on multiple organfailure and disseminated intravascular coagulation in a sepsis model Thromb Res 60 1990 321 330
29. Y. Fujishima, K. Yokota, and T. Sukamoto The effect of danaparoid sodium (Danaparoid) on endotoxin-induced experimental disseminated intravascular coagulation (DIC) in rats Thromb Res 91 1998 221 227 (Pubitemid 28451942)
30. F.B. Taylor Jr., A. Chang, W. Ruf, J.H. Morrissey, L. Hinshaw, and R. Catlett Lethal E.coli septic shock is prevented by blocking tissue factor with monoclonal antibody Circ Shock 33 1991 127 134
31. S.M. Opal, J.E. Palardy, N.A. Parejo, and A.A. Creasey The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis Crit Care Med 29 2001 13 17 (Pubitemid 32125767)
32. F.E. Almus, L.V.M. Rao, and S.I. Rapaport Decreased inducibility of tissue factor activity on human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin Thromb Res 50 1988 339 344
33. F.E. Almus, L.V.M. Rao, U.R. Pendurthi, L. Quattrochi, and S.I. Rapaport Mechanism for diminished Tissue Factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin Blood 77 1991 1256 1262
34. Y. Cadroy, D. Gaspin, D. Dupouy, J.C. Lormeau, B. Boneu, and P. Sié Heparin reverses the procoagulant properties of stimulated endothelial cells Thromb Haemost 75 1996 190 195 (Pubitemid 26051215)
35. G. Pepe, B. Giusti, M. Attanasio, A.M. Gori, P. Comeglio, and F. Martini Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparin Sem Thromb Haemost 23 1997 135 141 (Pubitemid 27276099)
36. R.J. Ludwig Therapeutic Use of Heparin beyond Anticoagulation Curr Drug Discov Technol 6 2009 281 289
37. U. Derhaschnig, T. Pernerstorfer, M. Knechtelsdorfer, U. Hollenstein, S. Panzer, and B. Jilma Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia Crit Care Med 31 2003 1108 1112 (Pubitemid 36444421)
38. K. Johnson, Y. Choi, E. DeGroot, I. Samuels, A. Creasey, and L. Aarden Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation J Immunol 160 1998 5130 5135 (Pubitemid 28215352)
39. A.K. Høgåsen, and T.G. Abrahamsen Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production Thromb Res 80 1995 179 184
40. C.S. Engstad, T.J. Gutteberg, and B. Osterud Modulation of blood cell activation by four commonly used anticoagulants Thromb Haemost 77 1997 690 696 (Pubitemid 27182965)
41. M. Attanasio, A.M. Gori, B. Giusti, G. Pepe, P. Comeglio, and T. Brunelli Cytokine gene expression in human LPS- and IFN gamma-stimulated mononuclear cells is inhibited by heparin Thromb Haemost 79 1998 959 962 (Pubitemid 28224732)
42. A.M. Gori, M. Attanasio, A. Gazzini, L. Rossi, L. Lucarini, and S. Miletti Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulphated heparin-like semi-synthetic derivatives J Thromb Haemost 2 2004 1657 1662 (Pubitemid 40186184)
43. H. Hochart, P.V. Jenkins, O.P. Smith, and B. White Low molecular weight and unfractionated heparin induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes Br J Haematol 133 2006 62 67 (Pubitemid 43327199)
44. V.H. Thourani, S.S. Brar, T.P. Kennedy, L.R. Thornton, J.A. Watts, and R.S. Ronson Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury Am J Physiol Heart Circ Physiol 278 2000 2084 2093
45. J.M. Cavaillon, C. Marie, M. Caroff, A. Ledur, I. Godard, and D. Poulain CD14/LPS receptor exhibits lectin-like properties J Endotoxin Res 3 1996 471 480
46. S. Anastase-Ravion, C. Blondin, B. Cholley, N. Haeffner-Cavaillon, J.J. Castellot, and D. Letourneur Heparin inhibits lipopolysaccharide (LPS) binding to leukocytes and LPS-induced cytokine production J Biomed Mater Res A 66 2003 376 384 (Pubitemid 37517238)
47. M. Wang, J. He, B. Mei, X. Ma, and Z. Huo Therapeutic Effects and Anti-inflammatory Mechanisms of Heparin on Acute Lung Injury in Rabbits Acad Emerg Med 15 2008 656 663
48. W.T. McBride, M.A. Armstrong, and T.J. McMurray An investigation of the effects of heparin, low molecular weight heparin, protamine, and fentanyl on the balance of pro- and anti-inflammatory cytokines in in-vitro monocyte cultures Anaesthesia 51 1996 634 640 (Pubitemid 26238264)
49. M. Heinzelmann, M. Miller, A. Platz, L.E. Gordon, D.O. Herzig, and H.C. Polk Jr. Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes Ann Surg 229 1999 542 550 (Pubitemid 30191753)
50. M. Heinzelmann, and H. Bosshart Heparin binds to lipopolysaccharide (LPS)-binding protein, facilitates the transfer of LPS to CD14, and enhances LPS-induced activation of peripheral blood monocytes J Immunol 174 2005 2280 2287 (Pubitemid 40223976)
51. J.F. Dhainaut, N. Marin, A. Mignon, and C. Vinsonneau Hepatic response to sepsis: Interaction between coagulation and inflammatory processes Crit Care Med 29 2001 S42 S47 (Suppl.)